Problem 40
Question
A chemist at a pharmaceutical company is measuring equilibrium constants for reactions in which drug candidate molecules bind to a protein involved in cancer. The drug molecules bind the protein in a \(1: 1\) ratio to form a drugprotein complex. The protein concentration in aqueous solution at \(25^{\circ} \mathrm{C}\) is \(1.50 \times 10^{-6} \mathrm{M}\). Drug \(\mathrm{A}\) is introduced into the protein solution at an initial concentration of \(2.00 \times 10^{-6} \mathrm{M}\). Drug \(B\) is introduced into a separate, identical protein solution at an initial concentration of \(2.00 \times 10^{-6} \mathrm{M}\). At equilibrium, the drug A-protein solution has an A-protein complex concentration of \(1.00 \times 10^{-6} \mathrm{M}\), and the drug \(\mathrm{B}\) solution has a B-protein complex concentration of \(1.40 \times 10^{-6} \mathrm{M}\). Calculate the \(K_{c}\) value for the \(A\)-protein binding reaction and for the \(\mathrm{B}\) protein binding reaction. Assuming that the drug that binds more strongly will be more effective, which drug is the better choice for further research?
Step-by-Step Solution
VerifiedKey Concepts
Protein Binding
- **Equilibrium Constant:** This is a measure of the affinity of the drug for the protein. A higher value indicates a stronger affinity, meaning the drug binds more effectively to the protein.
- **1:1 Ratio:** In our exercise, the binding is in a 1:1 mole ratio, indicating that one molecule of drug binds to one molecule of protein.
- **Calculating Bound Concentrations:** To find out how many drug molecules have formed a complex with proteins, we subtract the equilibrium concentration of the complex from the initial concentrations of the drug and protein.
Pharmaceutical Chemistry
- **Drug Design:** Initially involves the creation of molecules that can interact strongly with their target proteins.
- **Equilibrium Studies:** Such studies entail evaluating how well a drug molecule binds to a protein, often with a focus on achieving the required balance between binding strength and therapeutic safety.
- **Evaluation of Kinetic Parameters:** This involves understanding how fast reactions occur and how drugs interact within a biological environment.
Reaction Kinetics
- **Rate of Reaction:** This refers to the speed at which the reactants form the products. Faster reactions can imply a quicker onset of the drug's effects.
- **Equilibrium State:** Eventually, the system reaches a state where the formation of the drug-protein complex and its dissociation occur at the same rate. It is in this state that the equilibrium constant is derived.
- **Impact on Drug Efficiency:** A drug that quickly reaches and maintains equilibrium can be more reliable in therapeutic settings.